312 related articles for article (PubMed ID: 28914666)
1. The regulation and importance of monocyte chemoattractant protein-1.
Bianconi V; Sahebkar A; Atkin SL; Pirro M
Curr Opin Hematol; 2018 Jan; 25(1):44-51. PubMed ID: 28914666
[TBL] [Abstract][Full Text] [Related]
2. Monocyte subtypes and the CCR2 chemokine receptor in cardiovascular disease.
França CN; Izar MCO; Hortêncio MNS; do Amaral JB; Ferreira CES; Tuleta ID; Fonseca FAH
Clin Sci (Lond); 2017 Jun; 131(12):1215-1224. PubMed ID: 28566450
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in CCR2 antagonists.
Xia M; Sui Z
Expert Opin Ther Pat; 2009 Mar; 19(3):295-303. PubMed ID: 19441905
[TBL] [Abstract][Full Text] [Related]
4. Role of MCP-1/CCR2 axis in renal fibrosis: Mechanisms and therapeutic targeting.
He S; Yao L; Li J
Medicine (Baltimore); 2023 Oct; 102(42):e35613. PubMed ID: 37861543
[TBL] [Abstract][Full Text] [Related]
5. Key determinants of selective binding and activation by the monocyte chemoattractant proteins at the chemokine receptor CCR2.
Huma ZE; Sanchez J; Lim HD; Bridgford JL; Huang C; Parker BJ; Pazhamalil JG; Porebski BT; Pfleger KDG; Lane JR; Canals M; Stone MJ
Sci Signal; 2017 May; 10(480):. PubMed ID: 28536301
[TBL] [Abstract][Full Text] [Related]
6. Targeting the CCL2-CCR2 axis for atheroprotection.
Georgakis MK; Bernhagen J; Heitman LH; Weber C; Dichgans M
Eur Heart J; 2022 May; 43(19):1799-1808. PubMed ID: 35567558
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo.
Han KH; Ryu J; Hong KH; Ko J; Pak YK; Kim JB; Park SW; Kim JJ
Circulation; 2005 Mar; 111(11):1439-47. PubMed ID: 15781755
[TBL] [Abstract][Full Text] [Related]
9. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies.
Daly C; Rollins BJ
Microcirculation; 2003 Jun; 10(3-4):247-57. PubMed ID: 12851642
[TBL] [Abstract][Full Text] [Related]
10. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
[TBL] [Abstract][Full Text] [Related]
11. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases.
Zhu S; Liu M; Bennett S; Wang Z; Pfleger KDG; Xu J
J Cell Physiol; 2021 Oct; 236(10):7211-7222. PubMed ID: 33782965
[TBL] [Abstract][Full Text] [Related]
12. Role of CCL2/CCR2 axis in the immunopathogenesis of rheumatoid arthritis: Latest evidence and therapeutic approaches.
Moadab F; Khorramdelazad H; Abbasifard M
Life Sci; 2021 Mar; 269():119034. PubMed ID: 33453247
[TBL] [Abstract][Full Text] [Related]
13. MCP-1/CCR2-dependent loop for fibrogenesis in human peripheral CD14-positive monocytes.
Sakai N; Wada T; Furuichi K; Shimizu K; Kokubo S; Hara A; Yamahana J; Okumura T; Matsushima K; Yokoyama H; Kaneko S
J Leukoc Biol; 2006 Mar; 79(3):555-63. PubMed ID: 16415174
[TBL] [Abstract][Full Text] [Related]
14. Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice.
Llorián-Salvador M; Pevida M; González-Rodríguez S; Lastra A; Fernández-García MT; Hidalgo A; Baamonde A; Menéndez L
Fundam Clin Pharmacol; 2016 Jun; 30(3):235-47. PubMed ID: 26820818
[TBL] [Abstract][Full Text] [Related]
15. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis.
Peterson KE; Errett JS; Wei T; Dimcheff DE; Ransohoff R; Kuziel WA; Evans L; Chesebro B
J Virol; 2004 Jun; 78(12):6449-58. PubMed ID: 15163738
[TBL] [Abstract][Full Text] [Related]
16. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
Bose S; Cho J
Arch Pharm Res; 2013 Sep; 36(9):1039-50. PubMed ID: 23771498
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol reduces MCP-1-induced chemotaxis and adhesion of THP-1 monocytes by inhibiting CCR2 gene expression.
Chuang SY; Yang SH; Pang JH
Biochem Biophys Res Commun; 2011 Jul; 411(2):402-8. PubMed ID: 21756880
[TBL] [Abstract][Full Text] [Related]
18. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
19. Blocking mast cell-mediated type I hypersensitivity in experimental allergic conjunctivitis by monocyte chemoattractant protein-1/CCR2.
Tominaga T; Miyazaki D; Sasaki S; Mihara S; Komatsu N; Yakura K; Inoue Y
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5181-8. PubMed ID: 19553621
[TBL] [Abstract][Full Text] [Related]
20. The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.
Burt D; Salvidio G; Tarabra E; Barutta F; Pinach S; Dentelli P; Camussi G; Perin PC; Gruden G
Am J Pathol; 2007 Dec; 171(6):1789-99. PubMed ID: 18055544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
